(Q42528634)
Statements
Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity (English)
J Brent Roaten
Marcelo G Kazanietz
Maria Jose Caloca
Paul J Bertics
Leonard Lothstein
Abby L Parrill
Mervyn Israel
Trevor W Sweatman